>>Lipids>> Sphingolipids>>C16 1-Deoxyceramide (m18:1/16:0)

C16 1-Deoxyceramide (m18:1/16:0) (Synonyms: C16:0 1-Deoxyceramide, C16:0 Ceramide (m18:1/16:0), Cer(m18:1/16:0), N-Hexadecanoyl-1-deoxy-4,5-dihydro-Sphingosine)

Catalog No.GC46975

A long-chain atypical ceramide

Products are for research use only. Not for human use. We do not sell to patients.

C16 1-Deoxyceramide (m18:1/16:0) Chemical Structure

Cas No.: 1246298-56-5

Size 가격 재고 수량
1 mg
US$324.00
재고 있음
5 mg
US$891.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

C16 1-Deoxyceramide (m18:1/16:0) is a long-chain atypical ceramide containing a 1-deoxysphingosine (m18:1(4E)) backbone. 1-Deoxysphingolipids are formed when serine palmitoyltransferase condenses palmitoyl-CoA with alanine instead of serine during sphingolipid synthesis.1,2 C16 1-Deoxyceramide (m18:1/16:0) has been found in RAW 264.7 cells.3

1.Steiner, R., Saied, E.M., Othman, A., et al.Elucidating the chemical structure of native 1-deoxysphingosineJ. Lipid Res.57(7)1194-1203(2016) 2.Alecu, I., Othman, A., Penno, A., et al.Cytotoxic 1-deoxysphingolipids are metabolized by a cytochrome P450-dependent pathwayJ. Lipid Res.58(1)60-71(2017) 3.JimÉnez-Rojo, N., Sot, J., Busto, J.V., et al.Biophysical properties of novel 1-deoxy-(dihydro)ceramides occurring in mammalian cellsBiophys. J.107(12)2850-2859(2014)

리뷰

Review for C16 1-Deoxyceramide (m18:1/16:0)

Average Rating: 5 ★★★★★ (Based on Reviews and 17 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for C16 1-Deoxyceramide (m18:1/16:0)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.